RxDoctor Payments Data

Michelle Chartier, DO

Family Medicine · Harbor Springs, MINPI 1104897107

Payments from drug & device makers

$313in general payments, 2019–2025

Across 19 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$69
  • Boehringer Ingelheim$61
  • Sunovion Pharmaceuticals Inc.$37
  • Pfizer$30
  • AbbVie$28
  • GSK$21
  • plus $66 from 4 others

What the payments were for

  • Food & beverage$30196%
  • Education$124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$313 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$34,277
Medicare patients
140
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$59,952
EliquisApixaban39$50,308
TrulicityDulaglutide35$40,005
MounjaroTirzepatide18$20,342
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$15,390
Breo ElliptaFluticasone/Vilanterol16$10,557
JanuviaSitagliptin Phosphate13$7,072
ZtlidoLidocaine13$4,511
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$4,230
Lidocaine20$3,638
LantusInsulin Glargine,hum.Rec.Anlog11$3,186
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,946
Ventolin HfaAlbuterol Sulfate27$2,597
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen189$2,557
Atorvastatin Calcium165$2,494

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$69$60,34753 claims
Novo NordiskOzempic$16$59,95249 claims
PfizerEliquis$30$50,30839 claims
GSKTrelegy Ellipta, Breo Ellipta$21$25,94728 claims
MerckJanuvia$16$7,07213 claims
AbbVieSynthroid$28$2,16316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Harbor Springs

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →